查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球運動醫學市場：按產品、應用和最終用戶 - 預測（~2029 年）
市場調查報告書
商品編碼
1559898

全球運動醫學市場：按產品、應用和最終用戶 - 預測（~2029 年）

Sports Medicine Market by Product (Repair (Fracture & Ligament), Reconstruction, Implant, Prosthetic, Arthroscopy, Physiotherapy, Orthobiologics, Brace), Application (Knee, Shoulder, Ankle, Hip, Spine), End-User - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 299 Pages | 訂單完成後即時交付

價格

全球運動醫學市場規模預計將從 2024 年的 67.9 億美元增至 2029 年的 94.5 億美元，預測期內複合年成長率為 6.8%。

該領域的重大進展支持了預計的市場成長。需求促進因素包括技術的創新和改進、治療效率的提高以及政府採取重大措施來增加人口的身體活動和預防運動傷害。一個限制因素是，與運動醫學相關的醫療設備成本高昂，可能使許多需要這種治療的人無法獲得這種治療。

調查範圍
調查年份 2022-2029
基準年 2023年
預測期 2024-2029
單元 100萬美元
部分 按產品、按應用、按最終用戶、按地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東/非洲

“從2022年到2029年，身體重組產品將創下最大的市場佔有率。”

許多接觸性運動，例如籃球、橄欖球和足球，都涉及需要重組、肌肉和肌腱固定以及骨骼和軟骨組織完全替換的損傷。在許多情況下，植入可用於替代缺失的骨骼，以恢復大面積的強度。此外，可能需要在受傷部位使用支架重組材料和骨科生物製劑。隨著時間的推移，骨折和韌帶損傷的頻率不斷增加。涉及前十字韌帶 (ACL) 的運動傷害極為常見。半月軟骨、肩迴旋肌和軟骨修復是治療 ACL 損傷的三種主要手術技術。半月軟骨修復是最常見的膝蓋治療方法。

“在預測期內，物理治療中心和診所將實現市場上最高的成長率。”

物理治療中心支持個人的生活方式並促進健康。物理治療師透過運動來幫助您恢復身心健康。該細分市場具有多種優勢。它可以減輕疼痛、加強關節運動、提供肌肉力量、減少發炎、改善患者的心血管功能。

“在預測期內，亞太地區將實現最高的市場成長率。”

亞太地區運動醫學市場正在顯著成長。預計亞太地區運動醫學市場成長率最高的原因有很多。最重要的是，戶外運動活動（無論是專業的還是休閒的）參與度的增加正在推動對運動醫學產品的需求。增加資金籌措和增加對奧運等各種體育賽事的參與正在促進運動醫學市場的成長。

本報告研究和分析了全球運動醫學市場，提供了關鍵促進因素和限制因素、競爭格局和未來趨勢的資訊。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

  • 運動醫學市場概況
  • 運動醫學市場：按地區
  • 亞太運動醫學市場：依國家、依最終使用者分類
  • 運動醫學市場：依主要國家分類

第5章市場概況

  • 介紹
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 任務
  • 產業趨勢
    • 整形外科機器人手術系統
    • 再生醫學
    • 生物力學、運動分析
  • 價值鏈分析
    • 研究與開發
    • 原物料採購及製造
    • 行銷、銷售、分銷、售後服務
  • 波特五力分析
  • 專利分析
  • 重大會議和活動（2024-2025）
  • 貿易資料分析
    • 導入資料
    • 匯出資料
  • 價格分析
    • 平均銷售價格趨勢：按地區
    • 前三名應用程式的平均售價趨勢：按主要企業分類
  • 主要相關利益者和採購標準
  • 未滿足的需求和主要問題
  • 生態系分析
  • 供應鏈分析
    • 知名企業
    • 小型企業
    • 最終用戶
  • 影響客戶業務的趨勢/干擾
  • 技術分析
    • 主要技術
    • 互補技術
    • 鄰近技術
  • 案例研究分析
  • 監管環境
    • 監管標準和核准
    • 監管機構、政府機構和其他組織
  • 投資金籌措場景
  • 贖回場景
  • 生成式人工智慧對運動醫學市場的影響

第6章運動醫學市場：依應用分類

  • 介紹
  • 膝蓋受傷
  • 肩部受傷
  • 腳/腳踝受傷
  • 髖部和鼠蹊部受傷
  • 手肘/手腕受傷
  • 背部/脊椎受傷
  • 其他損壞

第7章運動醫學市場：依最終使用者分類

  • 介紹
  • 醫院
  • 門診手術中心
  • 物理治療中心/診所

第8章運動醫學市場：依產品

  • 介紹
  • 修復和重組產品
    • 骨折/韌帶修復產品
    • 關節鏡檢查設備
    • 植入
    • 骨科生物製劑
    • 矯正器具
  • 身體支持和恢復產品
    • 支架/支撐器具
    • 物理治療設備
    • 壓力衣
  • 配件

第9章運動醫學市場：按地區

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 亞太宏觀經濟展望
    • 日本
    • 中國
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中東/非洲
    • 中東和非洲宏觀經濟前景
    • 海灣合作理事會國家
    • 其他中東/非洲

第10章競爭格局

  • 概述
  • 主要企業策略/主要企業
  • 收益分析（2021-2024）
  • 市場佔有率分析（2023）
  • 企業評價矩陣：主要企業（2023年）
  • 企業評估矩陣：Start-Ups/中小企業（2023）
  • 公司評價及財務指標
  • 品牌/產品比較
  • 競爭場景

第11章 公司簡介

  • 主要企業
    • ARTHREX, INC.
    • SMITH+NEPHEW
    • STRYKER
    • DEPUY SYNTHES
    • ENOVIS
    • BREG, INC.
    • CONMED CORPORATION
    • ZIMMER BIOMET
    • RTI SURGICAL
    • PERFORMANCE HEALTH
    • BAUERFEIND
    • KARL STORZ
    • MUELLER SPORTS MEDICINE, INC.
    • OSSUR
    • OTTOBOCK
    • BIOTEK
    • ANIKA THERAPEUTICS, INC.
  • 其他公司
    • BIOVENTUS
    • MIACH ORTHOPAEDICS
    • MONOGRAM ORTHOPEDICS
    • EPIBONE
    • ORTHALIGN
    • BLUE OCEAN SPINE GMBH
    • NELA BIODYNAMICS
    • PARAGON 28, INC.
    • ATEC SPINE, INC.
    • MEDTRONIC

第12章附錄

Product Code: MD 1219

The global sports medicine market is expected to reach USD 9.45 Billion by 2029 from USD 6.79 Billion in 2024, growing at a CAGR of 6.8% during the forecast period. The anticipated market growth for sports medicine market is supported by significant progress made in the field. The factors enhancing the demand comprise innovation and improvements in technologies, improved therapeutic efficiency and uptake of major initiatives by government to increase the physical activity of citizens as well as to prevent sports related injuries. The limitations are the high cost of medical devices associated with sports medicine that may restrict many people in need from accessing such therapies.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million)
SegmentsBy Product, Application, End user, Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

"Body reconstruction products to register largest market share in 2022-2029."

Body reconstruction products include implants, fracture & ligament repair products, arthroscopy devices, prosthetics and orthobiologics. Products for body reconstruction include prosthesis, arthroscopy equipment, implants, fracture and ligament repair supplies, and guthobiologics. Numerous contact sports, including basketball, rugby, and football, entail injuries that necessitate reconstruction, muscle or tendon fix, or replacement of the complete bone or cartilage tissue. To restore strength to large regions, implants may be used in a number of cases to replace missing bone. Furthermore, the injured site may also require the utilization of scaffold reconstruction material and OrthoBiologics. The frequency of fractures and ligament damage has gone up over time. Sports injuries involving the anterior cruciate ligament (ACL) are by far the most frequent. Meniscus, rotator cuff, and cartilage repairs are the three primary surgical techniques for ACL injuries. Repairing meniscals is the most typical process performed on the knee.

"Physiotherapy centers and clinics to register highest growth rate in the market during the forecast period."

Physiotherapy centers offer support and promote health of an individual's lifestyle. Physiotherapists utlizes exercises and help to recover physical and mental well-being. There are various advantages associated with this segment. It can decrease pain, enhance joint movement, give strength, reduce inflammation, and betters cardio-respiratory role of the patient.

"Asia Pacific to register highest growth rate in the market during the forecast period."

The highest CAGR was registered by the APAC region throughout the forecast period from 2024-2029. Asia Pacific comprise India, China, Japan, Australia, South Korea and RoAPAC. The Asia-Pacific region has shown significance growth for sports medicine market. Asia Pacific is projected to grow at a highest rate in sports medicine market for numerous reasons. Most importantly, sports medicine products are in high demand due to increase in participation in outdoor sports activities for professional or recreational purpose. Rise in fundings and increase in participation in different sports events such as Olympics are enhancing the growth of sports medicine market.

A number of drivers were responsible for the upswing, including:

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
  • By Designation: C-level-- 10%, Director-level-14%, and Others-76%
  • By Region: North America-40%, Europe-30%, Asia Pacific-22%, Rest of the World -8%.

Prominent players in this market are Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), Breg, Inc. (US), Conmed Corporation (US), Zimmer Biomet Holdings, INC. (US), Enovis (US), RTI Surgical (US), Performance Health International Limited (US), Bauerfeind AG (Germany), Arthrex, INC. (US), Karl Stprz GMBH & CP. KG (Germany), Mueller Sports Medicine, INC. (US), Ossur (Iceland), Ottobock SE & CO. KGAA (Germany), Biotek (India), Anika Therapeutics (US) among others.

Research Coverage

Products, applications, end users, and regions are the basis for the segmentation. The drivers, constraints, opportunities, and challenges that affect the market's growth are all examined in this study. For stakeholders, the report outlines the prospects and challenges in the sports medicine sector. There are also more specifics on competitive landscapes of key players. This study assesses micro markets in terms of their potential, growth trends, and contributions to the global sports medicine industry. With a focus on five key regions, the report projects a rise in market segment revenues.

Key Benefits of Buying the Report:

The report aims to assist new entrants and top players in the in sports medicine market in understanding the sustainability of investments. It also addresses the availability of comprehensive data for these purposes. These are the main benefits of purchasing the report. It will support thorough risk assessment procedures and investment decision-making. It provides accurate market segmentation, such as that based on end users and geographic factors, providing targeted segments with customized information. Additionally, it assesses the most important trends, difficulties, growth factors, and opportunities related to the same, enabling intelligent judgment and strategic decision-making.

The report provides the insights on the following pointers:

Analysis of the key drivers, restraints, opportunities, and challenges affecting the growth of the sports medicine market: Innovative technology and rise in cases of sports injury; high cost of devices and strict regulations; growing number of hospitals and increased therapies.

Product Development/Innovation: Overview of pipeline technologies, research & development endeavors and introduction of novel product & service for the sports medicine industry.

Market Development: Comprehensive details regarding profitable markets: the study examines the sports medicine business in several geographical areas.

Market Diversification: Thorough understanding of novel products, unexplored regions, current advancements, and investments in the sports medicine market.

Competitive Assessment: Detailed assessment of market share, service offerings leading strategies of key players such as Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), Zimmer Biomet Holdings, INC. (US) and Arthrex, INC. (US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 INCLUSIONS AND EXCLUSIONS
  • 1.4 STUDY SCOPE
    • 1.4.1 MARKETS COVERED
    • 1.4.2 YEARS CONSIDERED
    • 1.4.3 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
  • 1.7 IMPACT OF GEN AI

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH DESIGN
    • 2.2.1 SECONDARY RESEARCH
    • 2.2.2 PRIMARY RESEARCH
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key industry insights
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Company revenue estimation approach
      • 2.3.1.2 Customer-based market estimation approach
    • 2.3.2 TOP-DOWN APPROACH
      • 2.3.2.1 Primary interviews
      • 2.3.2.2 CAGR projections
  • 2.4 DATA TRIANGULATION
  • 2.5 MARKET SHARE ASSESSMENT
  • 2.6 RESEARCH ASSUMPTIONS
    • 2.6.1 METHODOLOGY-RELATED ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
  • 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 SPORTS MEDICINE MARKET OVERVIEW
  • 4.2 SPORTS MEDICINE MARKET, BY REGION
  • 4.3 ASIA PACIFIC SPORTS MEDICINE MARKET, BY COUNTRY AND END USER
  • 4.4 SPORTS MEDICINE MARKET, BY KEY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising incidence of sports injuries
      • 5.2.1.2 Increasing innovations in products and treatments
      • 5.2.1.3 Growing adoption of 3D printing
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of implants and other devices
      • 5.2.2.2 Elevated risk of complications in sports injuries
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging sports leagues and events
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Risks associated with invasive injuries
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 ROBOTIC SURGICAL SYSTEMS FOR ORTHOPEDICS
    • 5.3.2 REGENERATIVE MEDICINE
    • 5.3.3 BIOMECHANICS AND MOTION ANALYSIS
  • 5.4 VALUE CHAIN ANALYSIS
    • 5.4.1 RESEARCH & DEVELOPMENT
    • 5.4.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING
    • 5.4.3 MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES
  • 5.5 PORTER'S FIVE FORCES ANALYSIS
    • 5.5.1 THREAT OF NEW ENTRANTS
    • 5.5.2 THREAT OF SUBSTITUTES
    • 5.5.3 BARGAINING POWER OF SUPPLIERS
    • 5.5.4 BARGAINING POWER OF BUYERS
    • 5.5.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.6 PATENT ANALYSIS
  • 5.7 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.8 TRADE DATA ANALYSIS
    • 5.8.1 IMPORT DATA
    • 5.8.2 EXPORT DATA
  • 5.9 PRICING ANALYSIS
    • 5.9.1 AVERAGE SELLING PRICE TREND, BY REGION
    • 5.9.2 AVERAGE SELLING PRICE TREND OF TOP 3 APPLICATIONS, BY KEY PLAYER
  • 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.10.2 BUYING CRITERIA
  • 5.11 UNMET NEEDS AND KEY PAIN POINTS
  • 5.12 ECOSYSTEM ANALYSIS
  • 5.13 SUPPLY CHAIN ANALYSIS
    • 5.13.1 PROMINENT COMPANIES
    • 5.13.2 SMALL AND MEDIUM-SIZED ENTERPRISES
    • 5.13.3 END USERS
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
  • 5.15 TECHNOLOGY ANALYSIS
    • 5.15.1 KEY TECHNOLOGIES
      • 5.15.1.1 Wearable technology
      • 5.15.1.2 Rehabilitation technology
      • 5.15.1.3 Artificial intelligence and machine learning
      • 5.15.1.4 3D printing and customization
    • 5.15.2 COMPLEMENTARY TECHNOLOGIES
      • 5.15.2.1 Biomechanics analysis
      • 5.15.2.2 Regenerative medicine
      • 5.15.2.3 Virtual reality and augmented reality
    • 5.15.3 ADJACENT TECHNOLOGIES
      • 5.15.3.1 Fitness and health apps
      • 5.15.3.2 Telehealth platforms
      • 5.15.3.3 Internet of Things
      • 5.15.3.4 Data analytics and performance management software
      • 5.15.3.5 Genomics and personalized medicine
  • 5.16 CASE STUDY ANALYSIS
    • 5.16.1 ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION AND CHONDROPLASTY OF KNEE
    • 5.16.2 EFFECTIVENESS OF OSTEOPATHY IN TREATING SPORTS INJURIES
    • 5.16.3 TOTAL HIP REPLACEMENT WITH AVASCULAR NECROSIS
  • 5.17 REGULATORY LANDSCAPE
    • 5.17.1 REGULATORY STANDARDS AND APPROVALS
      • 5.17.1.1 North America
        • 5.17.1.1.1 US
        • 5.17.1.1.2 Canada
      • 5.17.1.2 Europe
      • 5.17.1.3 Asia Pacific
        • 5.17.1.3.1 Japan
        • 5.17.1.3.2 China
        • 5.17.1.3.3 India
    • 5.17.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.18 INVESTMENT AND FUNDING SCENARIO
  • 5.19 REIMBURSEMENT SCENARIO
  • 5.20 IMPACT OF GEN AI ON SPORTS MEDICINE MARKET

6 SPORTS MEDICINE MARKET, BY APPLICATION

  • 6.1 INTRODUCTION
  • 6.2 KNEE INJURIES
    • 6.2.1 GROWING CASES OF COLLATERAL LIGAMENT INJURIES AND TENDON TEARS TO FUEL MARKET
  • 6.3 SHOULDER INJURIES
    • 6.3.1 ADVANCEMENTS IN ARTHROSCOPIC SURGICAL TECHNOLOGY TO AID GROWTH
  • 6.4 FOOT & ANKLE INJURIES
    • 6.4.1 RISING PREFERENCE FOR FOOT & ANKLE RECONSTRUCTIONS TO AUGMENT GROWTH
  • 6.5 HIP & GROIN INJURIES
    • 6.5.1 SURGE IN OSTEOARTHRITIS CASES TO FACILITATE GROWTH
  • 6.6 ELBOW & WRIST INJURIES
    • 6.6.1 INCREASED HEALTHCARE EXPENDITURE TO EXPEDITE GROWTH
  • 6.7 BACK & SPINE INJURIES
    • 6.7.1 RISING EMPHASIS ON ENHANCING PATIENT OUTCOMES TO CONTRIBUTE TO MARKET GROWTH
  • 6.8 OTHER INJURIES

7 SPORTS MEDICINE MARKET, BY END USER

  • 7.1 INTRODUCTION
  • 7.2 HOSPITALS
    • 7.2.1 COMPLEX DIAGNOSTIC AND THERAPEUTIC PROCEDURES TO DRIVE MARKET
  • 7.3 AMBULATORY SURGERY CENTERS
    • 7.3.1 LIMITED HOSPITALIZATION AND BETTER AFFORDABILITY TO AID GROWTH
  • 7.4 PHYSIOTHERAPY CENTERS & CLINICS
    • 7.4.1 COST-EFFECTIVE AND NON-SURGICAL METHOD TO ACCELERATE GROWTH

8 SPORTS MEDICINE MARKET, BY PRODUCT

  • 8.1 INTRODUCTION
  • 8.2 REPAIR & RECONSTRUCTION PRODUCTS
    • 8.2.1 FRACTURE & LIGAMENT REPAIR PRODUCTS
      • 8.2.1.1 High incidence of sports and recreation-related trauma to encourage growth
    • 8.2.2 ARTHROSCOPY DEVICES
      • 8.2.2.1 Ability to minimize risk of infections and reduce recovery time to favor market growth
    • 8.2.3 IMPLANTS
      • 8.2.3.1 Growing popularity of minimally invasive surgical procedures to boost market
    • 8.2.4 ORTHOBIOLOGICS
      • 8.2.4.1 Ongoing research in regenerative medicine to promote growth
    • 8.2.5 PROSTHETICS
      • 8.2.5.1 Innovations in bionic technology, sensor technology, artificial intelligence, and micromechatronics to drive market
  • 8.3 BODY SUPPORT & RECOVERY PRODUCTS
    • 8.3.1 BRACES & SUPPORTS
      • 8.3.1.1 Growing recommendations from physicians to augment growth
    • 8.3.2 PHYSIOTHERAPY EQUIPMENT
      • 8.3.2.1 Thermal therapy equipment
        • 8.3.2.1.1 Increasing availability of reusable hot and cold packs to expedite growth
      • 8.3.2.2 Electrostimulation equipment
        • 8.3.2.2.1 Growing advancements in electronics to propel market
      • 8.3.2.3 Other physiotherapy equipment
    • 8.3.3 COMPRESSION CLOTHING
      • 8.3.3.1 Surge in fitness centers and exercises in daily routines to speed up growth
  • 8.4 ACCESSORIES
    • 8.4.1 NEED FOR INJURY PREVENTION AND MANAGEMENT TO SUPPORT GROWTH

9 SPORTS MEDICINE MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 Favorable research activities and funding to favor market growth
    • 9.2.3 CANADA
      • 9.2.3.1 Growing prominence of regenerative medicine and stem cell therapy to fuel market
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 Increased participation in sports and awareness of healthy lifestyles to sustain growth
    • 9.3.3 UK
      • 9.3.3.1 Availability of funding for sports medicine and athlete support to boost market
    • 9.3.4 ITALY
      • 9.3.4.1 Rise in sports-related injuries to augment growth
    • 9.3.5 FRANCE
      • 9.3.5.1 Initiatives related to Olympics to contribute to market growth
    • 9.3.6 SPAIN
      • 9.3.6.1 Rising popularity of football and high risk of injuries to fuel market
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 JAPAN
      • 9.4.2.1 Rising number of total hip arthroplasty procedures and sports medicine fellowships to aid growth
    • 9.4.3 CHINA
      • 9.4.3.1 Growing focus on attaining higher fitness levels to drive market
    • 9.4.4 AUSTRALIA
      • 9.4.4.1 Surge in anterior cruciate ligament construction surgeries to encourage growth
    • 9.4.5 INDIA
      • 9.4.5.1 Booming sports infrastructure facilities to encourage growth
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Favorable monetary support for sports-related activities to boost market
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Growing number of international sports events to propel market
    • 9.5.3 MEXICO
      • 9.5.3.1 Growth of private healthcare facilities to fuel market
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 9.6.2 GCC COUNTRIES
      • 9.6.2.1 Strategic acquisitions and development of world-class stadiums to expedite growth
    • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SPORTS MEDICINE MARKET
  • 10.3 REVENUE ANALYSIS, 2021-2024
  • 10.4 MARKET SHARE ANALYSIS, 2023
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Product footprint
      • 10.5.5.3 Application footprint
      • 10.5.5.4 End-user footprint
      • 10.5.5.5 Region footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING
  • 10.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES AND APPROVALS
    • 10.9.2 DEALS
    • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 ARTHREX, INC.
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product launches and approvals
        • 11.1.1.3.2 Deals
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses and competitive threats
    • 11.1.2 SMITH+NEPHEW
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Product launches and approvals
        • 11.1.2.3.2 Deals
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Right to win
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses and competitive threats
    • 11.1.3 STRYKER
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product launches and approvals
        • 11.1.3.3.2 Deals
        • 11.1.3.3.3 Expansions
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses and competitive threats
    • 11.1.4 DEPUY SYNTHES
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Product launches and approvals
        • 11.1.4.3.2 Deals
      • 11.1.4.4 MnM view
        • 11.1.4.4.1 Right to win
        • 11.1.4.4.2 Strategic choices
        • 11.1.4.4.3 Weaknesses and competitive threats
    • 11.1.5 ENOVIS
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Product launches and approvals
        • 11.1.5.3.2 Deals
        • 11.1.5.3.3 Expansions
      • 11.1.5.4 MnM view
        • 11.1.5.4.1 Right to win
        • 11.1.5.4.2 Strategic choices
        • 11.1.5.4.3 Weaknesses and competitive threats
    • 11.1.6 BREG, INC.
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Product launches and approvals
        • 11.1.6.3.2 Deals
    • 11.1.7 CONMED CORPORATION
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Deals
    • 11.1.8 ZIMMER BIOMET
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Product launches and approvals
        • 11.1.8.3.2 Deals
        • 11.1.8.3.3 Other developments
    • 11.1.9 RTI SURGICAL
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
      • 11.1.9.3 Recent developments
        • 11.1.9.3.1 Deals
        • 11.1.9.3.2 Other developments
    • 11.1.10 PERFORMANCE HEALTH
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products offered
      • 11.1.10.3 Recent developments
        • 11.1.10.3.1 Deals
    • 11.1.11 BAUERFEIND
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products offered
      • 11.1.11.3 Recent developments
        • 11.1.11.3.1 Product launches and approvals
    • 11.1.12 KARL STORZ
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products offered
      • 11.1.12.3 Recent developments
        • 11.1.12.3.1 Deals
    • 11.1.13 MUELLER SPORTS MEDICINE, INC.
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products offered
      • 11.1.13.3 Recent developments
        • 11.1.13.3.1 Deals
    • 11.1.14 OSSUR
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products offered
      • 11.1.14.3 Recent developments
        • 11.1.14.3.1 Product launches and approvals
        • 11.1.14.3.2 Deals
        • 11.1.14.3.3 Expansions
    • 11.1.15 OTTOBOCK
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products offered
      • 11.1.15.3 Recent developments
        • 11.1.15.3.1 Product launches and approvals
        • 11.1.15.3.2 Deals
    • 11.1.16 BIOTEK
      • 11.1.16.1 Business overview
      • 11.1.16.2 Products offered
    • 11.1.17 ANIKA THERAPEUTICS, INC.
      • 11.1.17.1 Business overview
      • 11.1.17.2 Products offered
  • 11.2 OTHER PLAYERS
    • 11.2.1 BIOVENTUS
    • 11.2.2 MIACH ORTHOPAEDICS
    • 11.2.3 MONOGRAM ORTHOPEDICS
    • 11.2.4 EPIBONE
    • 11.2.5 ORTHALIGN
    • 11.2.6 BLUE OCEAN SPINE GMBH
    • 11.2.7 NELA BIODYNAMICS
    • 11.2.8 PARAGON 28, INC.
    • 11.2.9 ATEC SPINE, INC.
    • 11.2.10 MEDTRONIC

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 SPORTS MEDICINE MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 SPORTING EVENTS WORLDWIDE, 2023-2024
  • TABLE 3 SPORTS MEDICINE MARKET: IMPACT OF PORTER'S FIVE FORCES
  • TABLE 4 INNOVATIONS AND PATENT REGISTRATIONS, 2022-2024
  • TABLE 5 SPORTS MEDICINE MARKET: KEY CONFERENCES AND EVENTS, 2024-2025
  • TABLE 6 IMPORT DATA FOR HS CODE 902750, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 7 EXPORT DATA FOR HS CODE 902750, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 8 AVERAGE SELLING PRICE OF SPORTS MEDICINE EQUIPMENT, BY REGION, 2021-2023 (USD THOUSAND)
  • TABLE 9 AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER, 2023 (USD)
  • TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
  • TABLE 11 KEY BUYING CRITERIA, BY END USER
  • TABLE 12 SPORTS MEDICINE MARKET: CURRENT UNMET NEEDS
  • TABLE 13 SPORTS MEDICINE MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 14 REGULATORY STANDARDS/APPROVALS FOR SPORTS MEDICINE, BY COUNTRY
  • TABLE 15 US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION
  • TABLE 16 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 17 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 18 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICALS AND MEDICAL DEVICES AGENCY
  • TABLE 19 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 25 MAJOR CPT CODES FOR ORTHOPEDIC SURGERY IN US, 2023
  • TABLE 26 SPORTS MEDICINE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 27 SPORTS MEDICINE MARKET FOR KNEE INJURIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 28 SPORTS MEDICINE MARKET FOR SHOULDER INJURIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 29 SPORTS MEDICINE MARKET FOR FOOT & ANKLE INJURIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 30 SPORTS MEDICINE MARKET FOR HIP & GROIN INJURIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 31 SPORTS MEDICINE MARKET FOR ELBOW & WRIST INJURIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 32 SPORTS MEDICINE MARKET FOR BACK & SPINE INJURIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 33 SPORTS MEDICINE MARKET FOR OTHER INJURIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 34 SPORTS MEDICINE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 35 SPORTS MEDICINE MARKET FOR HOSPITALS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 36 SPORTS MEDICINE MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 37 SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY CENTERS & CLINICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 38 SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 39 SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 40 SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 41 SPORTS MEDICINE MARKET FOR FRACTURE & LIGAMENT REPAIR PRODUCTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 42 SPORTS MEDICINE MARKET FOR ARTHROSCOPY DEVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 43 SPORTS MEDICINE MARKET FOR IMPLANTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 44 SPORTS MEDICINE MARKET FOR ORTHOBIOLOGICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 45 SPORTS MEDICINE MARKET FOR PROSTHETICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 46 SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 47 SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 48 SPORTS MEDICINE MARKET FOR BRACES & SUPPORTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 49 SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 50 SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 51 SPORTS MEDICINE MARKET FOR THERMAL THERAPY EQUIPMENT, BY REGION, 2022-2029(USD MILLION)
  • TABLE 52 SPORTS MEDICINE MARKET FOR ELECTROSTIMULATION EQUIPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 53 SPORTS MEDICINE MARKET FOR OTHER PHYSIOTHERAPY EQUIPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 54 SPORTS MEDICINE MARKET FOR COMPRESSION CLOTHING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 55 SPORTS MEDICINE MARKET FOR ACCESSORIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 56 SPORTS MEDICINE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 57 NORTH AMERICA: SPORTS MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 NORTH AMERICA: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 59 NORTH AMERICA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 60 NORTH AMERICA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 61 NORTH AMERICA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 62 NORTH AMERICA: SPORTS MEDICINE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 63 NORTH AMERICA: SPORTS MEDICINE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 64 NORTH AMERICA: MACROECONOMIC OUTLOOK
  • TABLE 65 US: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 66 US: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 67 US: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 68 US: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 69 CANADA: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 70 CANADA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 71 CANADA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 72 CANADA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 73 EUROPE: SPORTS MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 74 EUROPE: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 75 EUROPE: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 76 EUROPE: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 77 EUROPE: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 78 EUROPE: SPORTS MEDICINE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 79 EUROPE: SPORTS MEDICINE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 80 EUROPE: MACROECONOMIC OUTLOOK
  • TABLE 81 GERMANY: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 82 GERMANY: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 83 GERMANY: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 84 GERMANY: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 85 UK: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 86 UK: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 87 UK: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 88 UK: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 89 ITALY: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 90 ITALY: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 91 ITALY: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 92 ITALY: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 93 FRANCE: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 94 FRANCE: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 95 FRANCE: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 96 FRANCE: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 97 SPAIN: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 98 SPAIN: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 99 SPAIN: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 100 SPAIN: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 101 INDICATIVE LIST OF CONFERENCES IN REST OF EUROPE, 2022-2024
  • TABLE 102 REST OF EUROPE: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 103 REST OF EUROPE: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 104 REST OF EUROPE: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 105 REST OF EUROPE: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: SPORTS MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 108 ASIA PACIFIC: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 111 ASIA PACIFIC: SPORTS MEDICINE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: SPORTS MEDICINE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 113 ASIA PACIFIC: MACROECONOMIC OUTLOOK
  • TABLE 114 INDICATIVE LIST OF CONFERENCES IN JAPAN, 2024
  • TABLE 115 JAPAN: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 116 JAPAN: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 117 JAPAN: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 118 JAPAN: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 119 CHINA: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 120 CHINA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 121 CHINA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 122 CHINA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 123 AUSTRALIA: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 124 AUSTRALIA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 125 AUSTRALIA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 126 AUSTRALIA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 127 INDIA: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 128 INDIA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 129 INDIA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 130 INDIA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 131 SOUTH KOREA: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 132 SOUTH KOREA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 133 SOUTH KOREA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 134 SOUTH KOREA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 135 REST OF ASIA PACIFIC: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 136 REST OF ASIA PACIFIC: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 137 REST OF ASIA PACIFIC: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 138 REST OF ASIA PACIFIC: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 139 LATIN AMERICA: SPORTS MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 140 LATIN AMERICA: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 141 LATIN AMERICA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 142 LATIN AMERICA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 143 LATIN AMERICA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 144 LATIN AMERICA: SPORTS MEDICINE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 145 LATIN AMERICA: SPORTS MEDICINE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 146 LATIN AMERICA: MACROECONOMIC OUTLOOK
  • TABLE 147 BRAZIL: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 148 BRAZIL: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 149 BRAZIL: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 150 BRAZIL: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 151 INDICATIVE LIST OF CONFERENCES IN MEXICO, 2024-2025
  • TABLE 152 MEXICO: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 153 MEXICO: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 154 MEXICO: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 155 MEXICO: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 156 REST OF LATIN AMERICA: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 157 REST OF LATIN AMERICA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 158 REST OF LATIN AMERICA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 159 REST OF LATIN AMERICA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 160 MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 161 MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 162 MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 163 MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 165 MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 166 MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 167 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
  • TABLE 168 GCC COUNTRIES: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 169 GCC COUNTRIES: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 170 GCC COUNTRIES: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 171 GCC COUNTRIES: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 172 REST OF MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 173 REST OF MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET FOR REPAIR & RECONSTRUCTION PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 174 REST OF MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET FOR BODY SUPPORT & RECOVERY PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 175 REST OF MIDDLE EAST & AFRICA: SPORTS MEDICINE MARKET FOR PHYSIOTHERAPY EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 176 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SPORTS MEDICINE MARKET
  • TABLE 177 SPORTS MEDICINE MARKET: DEGREE OF COMPETITION
  • TABLE 178 SPORTS MEDICINE MARKET: PRODUCT FOOTPRINT
  • TABLE 179 SPORTS MEDICINE MARKET: APPLICATION FOOTPRINT
  • TABLE 180 SPORTS MEDICINE MARKET: END-USER FOOTPRINT
  • TABLE 181 SPORTS MEDICINE MARKET: REGION FOOTPRINT
  • TABLE 182 SPORTS MEDICINE MARKET: DETAILED LIST OF STARTUPS/SMES
  • TABLE 183 SPORTS MEDICINE MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 184 SPORTS MEDICINE MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 185 SPORTS MEDICINE MARKET: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 186 SPORTS MEDICINE MARKET: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 187 ARTHREX, INC.: COMPANY OVERVIEW
  • TABLE 188 ARTHREX, INC.: PRODUCTS OFFERED
  • TABLE 189 ARTHREX, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 190 ARTHREX, INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 191 SMITH+NEPHEW: COMPANY OVERVIEW
  • TABLE 192 SMITH+NEPHEW: PRODUCTS OFFERED
  • TABLE 193 SMITH+NEPHEW: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 194 SMITH+NEPHEW: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 195 STRYKER: PRODUCTS OFFERED
  • TABLE 196 STRYKER: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 197 STRYKER: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 198 STRYKER: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 199 DEPUY SYNTHES: COMPANY OVERVIEW
  • TABLE 200 DEPUY SYNTHES: PRODUCTS OFFERED
  • TABLE 201 DEPUY SYNTHES: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 202 DEPUY SYNTHES: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 203 ENOVIS: COMPANY OVERVIEW
  • TABLE 204 ENOVIS: PRODUCTS OFFERED
  • TABLE 205 ENOVIS: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 206 ENOVIS: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 207 ENOVIS: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 208 BREG, INC.: COMPANY OVERVIEW
  • TABLE 209 BREG, INC.: PRODUCTS OFFERED
  • TABLE 210 BREG, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 211 BREG, INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 212 CONMED CORPORATION: COMPANY OVERVIEW
  • TABLE 213 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 214 CONMED CORPORATION: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 215 ZIMMER BIOMET: COMPANY OVERVIEW
  • TABLE 216 ZIMMER BIOMET: PRODUCTS OFFERED
  • TABLE 217 ZIMMER BIOMET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 218 ZIMMER BIOMET: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 219 ZIMMER BIOMET: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2024
  • TABLE 220 RTI SURGICAL: COMPANY OVERVIEW
  • TABLE 221 RTI SURGICAL: PRODUCTS OFFERED
  • TABLE 222 RTI SURGICAL: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 223 RTI SURGICAL: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2024
  • TABLE 224 PERFORMANCE HEALTH: COMPANY OVERVIEW
  • TABLE 225 PERFORMANCE HEALTH: PRODUCTS OFFERED
  • TABLE 226 PERFORMANCE HEALTH: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 227 BAUERFEIND: COMPANY OVERVIEW
  • TABLE 228 BAUERFEIND: PRODUCTS OFFERED
  • TABLE 229 BAUERFEIND: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 230 KARL STORZ: COMPANY OVERVIEW
  • TABLE 231 KARL STORZ: PRODUCTS OFFERED
  • TABLE 232 KARL STORZ: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 233 MUELLER SPORTS MEDICINE, INC.: COMPANY OVERVIEW
  • TABLE 234 MUELLER SPORTS MEDICINE, INC.: PRODUCTS OFFERED
  • TABLE 235 MUELLER SPORTS MEDICINE, INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 236 OSSUR: COMPANY OVERVIEW
  • TABLE 237 OSSUR: PRODUCTS OFFERED
  • TABLE 238 OSSUR: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 239 OSSUR: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 240 OSSUR: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 241 OTTOBOCK: COMPANY OVERVIEW
  • TABLE 242 OTTOBOCK: PRODUCTS OFFERED
  • TABLE 243 OTTOBOCK: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 244 OTTOBOCK: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 245 BIOTEK: COMPANY OVERVIEW
  • TABLE 246 BIOTEK: PRODUCTS OFFERED
  • TABLE 247 ANIKA THERAPEUTICS, INC.: COMPANY OVERVIEW
  • TABLE 248 ANIKA THERAPEUTICS, INC.: PRODUCTS OFFERED
  • TABLE 249 BIOVENTUS: COMPANY OVERVIEW
  • TABLE 250 MIACH ORTHOPAEDICS: COMPANY OVERVIEW
  • TABLE 251 MONOGRAM ORTHOPEDICS: COMPANY OVERVIEW
  • TABLE 252 EPIBONE: COMPANY OVERVIEW
  • TABLE 253 ORTHALIGN: COMPANY OVERVIEW
  • TABLE 254 BLUE OCEAN SPINE GMBH: COMPANY OVERVIEW
  • TABLE 255 NELA BIODYNAMICS: COMPANY OVERVIEW
  • TABLE 256 PARAGON 28, INC.: COMPANY OVERVIEW
  • TABLE 257 ATEC SPINE, INC.: COMPANY OVERVIEW
  • TABLE 258 MEDTRONIC: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 SPORTS MEDICINE MARKET SEGMENTATION
  • FIGURE 2 SPORTS MEDICINE MARKET: RESEARCH DESIGN
  • FIGURE 3 KEY DATA FROM SECONDARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 7 SPORTS MEDICINE MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 8 SPORTS MEDICINE MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 9 SPORTS MEDICINE MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 11 DATA TRIANGULATION
  • FIGURE 12 SPORTS MEDICINE MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 SPORTS MEDICINE MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 SPORTS MEDICINE MARKET, BY REGION, 2024-2029
  • FIGURE 15 RISE IN NUMBER OF SPORTS-RELATED INJURIES AND DEVELOPMENT OF SPORTS TRAINING CENTERS TO DRIVE MARKET
  • FIGURE 16 NORTH AMERICA TO LEAD MARKET IN 2024
  • FIGURE 17 JAPAN AND HOSPITALS SEGMENT DOMINATED ASIA PACIFIC MARKET IN 2023
  • FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 19 SPORTS MEDICINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20 SPORTS MEDICINE MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 21 SPORTS MEDICINE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 22 SPORTS MEDICINE MARKET: PATENT ANALYSIS, 2013-2023
  • FIGURE 23 AVERAGE SELLING PRICE TREND OF SPORTS MEDICINE EQUIPMENT, BY REGION, 2021-2023 (USD THOUSAND) (1/2)
  • FIGURE 24 AVERAGE SELLING PRICE TREND OF SPORTS MEDICINE EQUIPMENT, BY REGION, 2021-2023 (USD THOUSAND) (2/2)
  • FIGURE 25 AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER, 2023 (USD)
  • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
  • FIGURE 27 KEY BUYING CRITERIA, BY END USER
  • FIGURE 28 SPORTS MEDICINE MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 SPORTS MEDICINE MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 30 REVENUE SHIFT AND NEW REVENUE POCKETS IN SPORTS MEDICINE MARKET
  • FIGURE 31 INVESTMENT AND FUNDING SCENARIO, 2018-2022
  • FIGURE 32 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2018-2022
  • FIGURE 33 DEAL VALUE OF INVESTMENT, BY KEY PLAYER, 2018-2022 (USD MILLION)
  • FIGURE 34 NORTH AMERICA: SPORTS MEDICINE MARKET SNAPSHOT
  • FIGURE 35 ASIA PACIFIC: SPORTS MEDICINE MARKET SNAPSHOT
  • FIGURE 36 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN SPORTS MEDICINE MARKET, 2021-2024 (USD MILLION)
  • FIGURE 37 SPORTS MEDICINE MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
  • FIGURE 38 SPORTS MEDICINE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 39 SPORTS MEDICINE MARKET: COMPANY FOOTPRINT
  • FIGURE 40 SPORTS MEDICINE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 43 SPORTS MEDICINE MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 44 SMITH+NEPHEW: COMPANY SNAPSHOT (2023)
  • FIGURE 45 STRYKER: COMPANY SNAPSHOT (2023)
  • FIGURE 46 DEPUY SYNTHES: COMPANY SNAPSHOT (2023)
  • FIGURE 47 ENOVIS: COMPANY SNAPSHOT (2023)
  • FIGURE 48 CONMED CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 49 ZIMMER BIOMET: COMPANY SNAPSHOT (2023)
  • FIGURE 50 OSSUR: COMPANY SNAPSHOT (2023)
  • FIGURE 51 ANIKA THERAPEUTICS, INC.: COMPANY SNAPSHOT (2023)